Figure 2From: The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in ratsChanges in the percentage of body weight gain in diabetic-hypercholesterolemic rats treated with the different modalities throughout the experimental period. *denotes statistical significance (p < 0.05) at the 4th week point compared to normal controls.Back to article page